Segment disclosures

Company overview

Covidien plc

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

33 dimension combinations 111 retained observations 6 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Active Pharmaceutical Ingredients · Pharmaceuticals

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:ActivePharmaceuticalIngredientsMember;us-gaap:StatementBusinessSegmentsAxis=cov:PharmaceuticalsMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30416000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24395000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25405000000 Unit120111123Open filing evidence

Airway And Ventilation Products · Medical Devices

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:AirwayAndVentilationProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30752000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24770000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25763000000 Unit120111123Open filing evidence

Contrast Products · Pharmaceuticals

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:ContrastProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:PharmaceuticalsMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30598000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24604000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25591000000 Unit120111123Open filing evidence

Endomechanical Instruments · Medical Devices

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:EndomechanicalInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-302342000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-242139000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-251982000000 Unit120111123Open filing evidence

Energy Devices · Medical Devices

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:EnergyDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-301170000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24992000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25867000000 Unit120111123Open filing evidence

Medical Surgical Products · Medical Supplies

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:MedicalSurgicalProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSuppliesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30441000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24412000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25417000000 Unit120111123Open filing evidence

Nursing Care Products · Medical Supplies

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:NursingCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSuppliesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30808000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24783000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25790000000 Unit120111123Open filing evidence

Original Equipment Manufacturer Products · Medical Supplies

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:OriginalEquipmentManufacturerProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSuppliesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30221000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24208000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25211000000 Unit120111123Open filing evidence

Other Products · Medical Devices

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:OtherProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30386000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24395000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25432000000 Unit120111123Open filing evidence

Oximetry And Monitoring Products · Medical Devices

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:OximetryAndMonitoringProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30853000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24755000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25636000000 Unit120111123Open filing evidence

Radiopharmaceuticals · Pharmaceuticals

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:RadiopharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:PharmaceuticalsMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30459000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24519000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25556000000 Unit120111123Open filing evidence

Sharpsafety Products · Medical Supplies

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:SharpsafetyProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSuppliesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30308000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24320000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25334000000 Unit120111123Open filing evidence

Soft Tissue Repair Products · Medical Devices

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:SoftTissueRepairProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30900000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24854000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25807000000 Unit120111123Open filing evidence

Specialty Pharmaceuticals · Pharmaceuticals

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:SpecialtyPharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:PharmaceuticalsMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-30494000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24473000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25544000000 Unit120111123Open filing evidence

Vascular Products · Medical Devices

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cov:VascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-301426000000 Unit120111123Open filing evidence
2009-09-26 – 2010-09-24810000000 Unit120111123Open filing evidence
2008-09-27 – 2009-09-25574000000 Unit120111123Open filing evidence

Medical Devices · Airway And Ventilation Products

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:AirwayAndVentilationProductsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24770000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25763000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26806000000 USD20101122Open filing evidence

Medical Devices · Endomechanical Instruments

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:EndomechanicalInstrumentsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-242139000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-251982000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-261928000000 USD20101122Open filing evidence

Medical Devices · Energy Devices

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:EnergyDevicesMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24992000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25867000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26805000000 USD20101122Open filing evidence

Medical Devices · Other Products

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:OtherProductsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24395000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25432000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26460000000 USD20101122Open filing evidence

Medical Devices · Oximetry And Monitoring Products

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:OximetryAndMonitoringProductsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24755000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25636000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26636000000 USD20101122Open filing evidence

Medical Devices · Soft Tissue Repair Products

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:SoftTissueRepairProductsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24854000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25807000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26786000000 USD20101122Open filing evidence

Medical Devices · Vascular Products

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:VascularProductsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24810000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25574000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26493000000 USD20101122Open filing evidence

Medical Supplies · Medical Surgical Products

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalSuppliesMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSurgicalProductsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24412000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25417000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26431000000 USD20101122Open filing evidence

Medical Supplies · Nursing Care Products

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalSuppliesMember;us-gaap:StatementBusinessSegmentsAxis=cov:NursingCareProductsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24783000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25790000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26784000000 USD20101122Open filing evidence

Medical Supplies · Original Equipment Manufacturer Products

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalSuppliesMember;us-gaap:StatementBusinessSegmentsAxis=cov:OriginalEquipmentManufacturerProductsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24208000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25211000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26212000000 USD20101122Open filing evidence

Medical Supplies · Sharpsafety Products

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalSuppliesMember;us-gaap:StatementBusinessSegmentsAxis=cov:SharpsafetyProductsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24320000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25334000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26362000000 USD20101122Open filing evidence

Pharmaceuticals · Active Pharmaceutical Ingredients

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:PharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:ActivePharmaceuticalIngredientsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24395000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25405000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26431000000 USD20101122Open filing evidence

Pharmaceuticals · Contrast Products

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:PharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:ContrastProductsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24604000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25591000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26635000000 USD20101122Open filing evidence

Pharmaceuticals · Radiopharmaceuticals

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:PharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:RadiopharmaceuticalsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24519000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25556000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26559000000 USD20101122Open filing evidence

Pharmaceuticals · Specialty Pharmaceuticals

Segment Reporting Information By Segment · Statement Business Segments

Source dimensions us-gaap:SegmentReportingInformationBySegmentAxis=cov:PharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:SpecialtyPharmaceuticalsMember
PeriodValueUnitFiledEvidence
2009-09-26 – 2010-09-24473000000 USD20101122Open filing evidence
2008-09-27 – 2009-09-25544000000 USD20101122Open filing evidence
2007-09-29 – 2008-09-26525000000 USD20101122Open filing evidence

Medical Devices

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-307829000000 Unit120111123Open filing evidence
2011-03-26 – 2011-06-241985000000 Unit120110729Open filing evidence
2010-09-25 – 2011-06-245739000000 Unit120110729Open filing evidence
2009-09-26 – 2010-09-246715000000 Unit120111123Open filing evidence
2010-03-27 – 2010-06-251630000000 Unit120110729Open filing evidence
2009-09-26 – 2010-06-254942000000 Unit120110729Open filing evidence
2008-09-27 – 2009-09-256061000000 Unit120111123Open filing evidence

Medical Supplies

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSuppliesMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-301778000000 Unit120111123Open filing evidence
2011-03-26 – 2011-06-24441000000 Unit120110729Open filing evidence
2010-09-25 – 2011-06-241297000000 Unit120110729Open filing evidence
2009-09-26 – 2010-09-241723000000 Unit120111123Open filing evidence
2010-03-27 – 2010-06-25427000000 Unit120110729Open filing evidence
2009-09-26 – 2010-06-251291000000 Unit120110729Open filing evidence
2008-09-27 – 2009-09-251752000000 Unit120111123Open filing evidence

Pharmaceuticals

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cov:PharmaceuticalsMember
PeriodValueUnitFiledEvidence
2010-09-25 – 2011-09-301967000000 Unit120111123Open filing evidence
2011-03-26 – 2011-06-24500000000 Unit120110729Open filing evidence
2010-09-25 – 2011-06-241460000000 Unit120110729Open filing evidence
2009-09-26 – 2010-09-241991000000 Unit120111123Open filing evidence
2010-03-27 – 2010-06-25507000000 Unit120110729Open filing evidence
2009-09-26 – 2010-06-251526000000 Unit120110729Open filing evidence
2008-09-27 – 2009-09-252096000000 Unit120111123Open filing evidence